Dear Visitor,

Our system has found that you are using an ad-blocking browser add-on.

We just wanted to let you know that our site content is, of course, available to you absolutely free of charge.

Our ads are the only way we have to be able to bring you the latest high-quality content, which is written by professional journalists, with the help of editors, graphic designers, and our site production and I.T. staff, as well as many other talented people who work around the clock for this site.

So, we ask you to add this site to your Ad Blocker’s "white list" or to simply disable your Ad Blocker while visiting this site.

Continue on this site freely
You are here: Home / Health / Heart Attacks Linked to NSAIDs
Heart Attacks Linked to Common NSAID Painkillers
Heart Attacks Linked to Common NSAID Painkillers
By Bradley J. Fikes Like this on Facebook Tweet this Link thison Linkedin Link this on Google Plus
Commonly used NSAID painkillers such as ibuprofen (sold under the brand name Advil) are associated with increased heart attack risk as early as the first week of use, according to a study published Tuesday.

The increased risk reaches its peak in the first month of use and then levels off, the study found. Higher doses were associated with increased risk. The risk declines after discontinuing the NSAIDs.

While the observational study in BMJ, formerly the British Medical Journal, cannot determine cause and effect, it reinforces previous warnings about potential harm from NSAIDs. Once placed online, the study can be found at

"All NSAIDs, including naproxen, were found to be associated with an increased risk of acute myocardial infarction," the study stated. "Risk of myocardial infarction with celecoxib was comparable to that of traditional NSAIDS and was lower than for rofecoxib."

The warning extends to diclofenac, sold over the counter and prescribed under the brand names of Zipsor, Zorvolex, Voltaren and Cataflam.

"Use for 8-30 days at a high dose was particularly harmful for ibuprofen (>1,200 mg/day), naproxen (>750 mg/day), and rofecoxib (>25 mg/day)," the study stated.

Ibuprofen and naproxen are sold over the counter generically and under the respective brand names of Motrin and Aleve. The prescription drug celecoxib is sold under the brand name Celebrex.

The prescription drug rofecoxib, sold under the brand Vioxx, was taken off the market in 2004 due to cardiovascular risks.

Michèle Bally of the University of Montreal Hospital Research Center led the study. At the time, she was an epidemiology doctoral student at McGill University in Canada.

The higher heart risk from Vioxx may explain why the cardiovascular problems associated with the NSAID class were first discovered in that drug, the study stated.

"Our study suggests a smaller risk of myocardial infarction exists with all other NSAIDs," it said.

Aspirin, technically an NSAID, is the great exception. The granddaddy of painkillers is known to have cardioprotective effects, and has long prescribed for that purpose.

Previous studies have pointed to a heightened risk of heart attack from NSAIDs.

In the new study, Canadian researchers reviewed four other studies in Canada or Europe, performed among the general population or the elderly.

"This patient level meta-analysis of acute myocardial infarction associated with NSAIDs involving 61,460 cases in 446,763 individuals is the largest investigation of its type, and its real world origin helps ensure that findings are broadly generalizable," the study stated.

© 2017 San Diego Union-Tribune under contract with NewsEdge/Acquire Media. All rights reserved.
Tell Us What You Think


Like Us on FacebookFollow Us on Twitter
© Copyright 2017 NewsFactor Network. All rights reserved. Member of Accuserve Ad Network.